Archives des Vaiomer original work

Microbiomes appear as a new source of therapeutic strategies to expand the efficacy and adherence to ICI treatments. More

Probiotic strains translocate to the tumor and improve ICI efficacy through indole-3-aldehyde release

Oct 5, 2023 | Highlights, Microbiomes & cancer, Vaiomer original work

DOI: 10.1016/j.cell.2023.03.011In recent years, several studies have shown the importance of both the gut and the...

Several studies have shown the importance of the gut microbiota in cancer progression and treatment response. More

The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi

Sep 22, 2023 | Highlights, Microbiomes & cancer, Vaiomer original work

DOI N°1: 10.1126/science.aay9189DOI N° 2: 10.1016/j.cell.2022.09.005Several studies have shown the importance of the...

Immunotherapy has revolutionized the treatment of several cancers. However, it remains elusive why only some patients benefit from these treatments and why some patients experience immune-related adverse events (irAEs). More

Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity

Sep 6, 2023 | Highlights, Microbiomes & cancer, Vaiomer original work

doi: 10.21037/atm-20-6427Immunotherapy has revolutionized the treatment of several cancers. However, it remains...

Immunotherapies (Immune Checkpoint Inhibitors, ICI) have become a powerful therapeutic strategy for treating a variety of cancers. It is a very exciting area, but with challenges. Indeed, the patients’ response to these therapies is often heterogeneous and not durable, with only 20 to 40% of patients actually responding. More

Resistance to anti-PD-1 immunotherapy can be attributed to the gut microbiome

Jun 23, 2023 | Highlights, Microbiomes & cancer, Vaiomer original work

DOI: 10.1126/science.aan4236 DOI: 10.1126/science.aao3290 DOI: 10.1126/science.aan370Immunotherapies (Immune...

Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the progression and resistance to immunotherapy of intestinal and non-intestinal cancers. more

Gut microbiota dysbiosis contributes to the tumorigenic process, even in extra-intestinal malignancies

Jun 12, 2023 | Highlights, Microbiomes & cancer, Vaiomer original work

doi: 10.1158/2159-8290.CD-21-0999Numerous metagenomics-based studies have associated gut microbiota dysbiosis with the...

Yde et al., explored the changes in the microbiota composition and metabolite levels induced by pre- and/or probiotic in an HFD mouse model. More

Metabolism and obesity: influence of prebiotics, probiotics and symbiotics on microbiomes and liver health

Apr 24, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

doi: 10.1371/journal.pone.0260765Prebiotic, probiotic and symbiotic treatments affect intestinal and adipose tissue...

In this article, Ciocan and colleagues explored the blood microbiome and metabolome in patients with major depressive episodes (MDE) before and after treatment and compared them to healthy controls. More

Metabolism and Major Depression: Blood microbiome and metabolome exploration

Apr 24, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1503/jpn.200159 Response to antidepressant is associated with blood microbiome and metabolome of patients with...

Suppli et al., studied the microbiome in liver biopsies and blood from healthy lean and obese patients. More

Metabolism and Obesity: the liver microbiome & the development of NAFLD

Apr 6, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

DOI: 10.1016/j.jhepr.2021.100299 Changes in the liver microbiome as a risk factor for the development of NAFLD in...

Bernard et al. explored the relationship between oral microbiota composition & fat taste sensitivity in obese patients after Vertical Sleeve Gastrectomy. More

Metabolism and Obesity: Oral microbiota and fat taste sensitivity

Apr 5, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work

doi: 10.3389/fnut.2022.1046454The relationship between oral microbiome and fat taste sensitivity in obese patients...

Vaiomer original work Articles

Probiotic strains translocate to the tumor and improve ICI efficacy through indole-3-aldehyde release

The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi

Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity

Resistance to anti-PD-1 immunotherapy can be attributed to the gut microbiome

Gut microbiota dysbiosis contributes to the tumorigenic process, even in extra-intestinal malignancies

Metabolism and obesity: influence of prebiotics, probiotics and symbiotics on microbiomes and liver health

Metabolism and Major Depression: Blood microbiome and metabolome exploration

Metabolism and Obesity: the liver microbiome & the development of NAFLD

Metabolism and Obesity: Oral microbiota and fat taste sensitivity

Research

Categorie

Archives

About Vaiomer :

Follow us !